| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein |
|---|---|---|---|---|
| 3222 | TTTHSWVSG | T | 647 | |
| 3223 | TTTHSWVSG | T | 648 | |
| 3224 | TTTHSWVSG | T | 649 | |
| 3225 | TTTHSWVS | S | 651 | |
| 3226 | TTTHSWVSG | S | 654 | |
| 10000968 | TTTHSWVSG | T | 2 | 648 |
| 10005699 | WPASPGSHSNDDFDNWSTFRPRTSSNASTISGRLSPIMTEQDDLGEGDVHSMVYPPSAAK | T | 23 | 317 |
| 10005700 | MMNPSSHTHPGHAQQTSAVNGRPLPHTVSTMPHTSGMNRLTQVK | S | 35 | 550 |
| 10005701 | DNVLPNQSFPHSVKTTTHSWVSG | T | 16 | 648 |
| 10005702 | DNVLPNQSFPHSVKTTTHSWVSG | S | 22 | 654 |
| 10005987 | TTTHSWVSGGIHRPVATMVSK | T | 3 | 649 |
| 10011401 | DNVLPNQSFPHSVKTTTHSWVSG | T | 648 | |
| 10016164 | TTTHSWVSG | T | 3 | 649 |
| 10016528 | TTTHSWVSG | S | 8 | 654 |
| 10026338 | TTTHSWVSG | S | 8 | 654 |
| 10029119 | TTTHSWVSG | T | 2 | 648 |
| 10033674 | TTTHSWVSG | T | 2 | 648 |
| 10036820 | TSSNASTISGR | 317 | ||
| 10037295 | TTTHSWVSG | 648 | ||
| 10037387 | TTTHSWVSG | 648 |
| ID | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Condition | log2Ratio | P Value | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|
| 3222 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
| 3223 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
| 3224 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
| 3225 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
| 3226 | MS | HTP | ambiguous | human | T cells | 29351928 | ||||
| 10000968 | MS | HTP | unambiguous | human | HeLa cells | 20 uM GalNAz/200 uM GalNAz | 3.870967742 | 30059200 | ||
| 10005699 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | ||||
| 10005700 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | ||||
| 10005701 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | ||||
| 10005702 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | ||||
| 10005987 | MS, site-directed mutagenesis | LTP | unambiguous | human | HEK 293 cells | 25944660 | This site was described as T646 of the protein sequence in the original paper | |||
| 10011401 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||||
| 10016164 | MS | HTP | unambiguous | human | MCF-7 cells | 32574038 | ||||
| 10016528 | MS | HTP | unambiguous | human | MCF-7 cells | 32574038 | ||||
| 10026338 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | ||||
| 10029119 | MS | HTP | unambiguous | human | SW620 cells | 35254053 | ||||
| 10033674 | MS | HTP | unambiguous | human | HEK 293T cells | glucose-deprived/glucose-sufficient | 0.87 | 37541260 | ||
| 10036820 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | ||||
| 10037295 | MS | HTP | unambiguous | human | HEK 293T cells | TMG/control | 0 | 30620550 | Peptide quantification value was applied to each modification site | |
| 10037387 | MS | HTP | unambiguous | human | HepG2 cells | orafenib sensitive/resistant | 1.201633861 | 30620550 | Peptide quantification value was applied to each modification site |
| ID | Peptide Seq | Site Residue | Position in Peptide | Position in Protein | Method | Analytical Throughput | Ambiguity | Species | Sample Type | Data Source PMID | Comments |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 3222 | TTTHSWVSG | T | 647 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
| 3223 | TTTHSWVSG | T | 648 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
| 3224 | TTTHSWVSG | T | 649 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
| 3225 | TTTHSWVS | S | 651 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
| 3226 | TTTHSWVSG | S | 654 | MS | HTP | ambiguous | human | T cells | 29351928 | ||
| 10000968 | TTTHSWVSG | T | 2 | 648 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | |
| 10005699 | WPASPGSHSNDDFDNWSTFRPRTSSNASTISGRLSPIMTEQDDLGEGDVHSMVYPPSAAK | T | 23 | 317 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | |
| 10005700 | MMNPSSHTHPGHAQQTSAVNGRPLPHTVSTMPHTSGMNRLTQVK | S | 35 | 550 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | |
| 10005701 | DNVLPNQSFPHSVKTTTHSWVSG | T | 16 | 648 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | |
| 10005702 | DNVLPNQSFPHSVKTTTHSWVSG | S | 22 | 654 | MS, site-directed mutagenesis | LTP | unambiguous | human | Fao cells | 18420577 | |
| 10005987 | TTTHSWVSGGIHRPVATMVSK | T | 3 | 649 | MS, site-directed mutagenesis | LTP | unambiguous | human | HEK 293 cells | 25944660 | This site was described as T646 of the protein sequence in the original paper |
| 10011401 | DNVLPNQSFPHSVKTTTHSWVSG | T | 648 | MS | HTP | unambiguous | human | HeLa cells | 30059200 | ||
| 10016164 | TTTHSWVSG | T | 3 | 649 | MS | HTP | unambiguous | human | MCF-7 cells | 32574038 | |
| 10016528 | TTTHSWVSG | S | 8 | 654 | MS | HTP | unambiguous | human | MCF-7 cells | 32574038 | |
| 10026338 | TTTHSWVSG | S | 8 | 654 | MS | HTP | unambiguous | human | HeLa cells | 35254053 | |
| 10029119 | TTTHSWVSG | T | 2 | 648 | MS | HTP | unambiguous | human | SW620 cells | 35254053 | |
| 10033674 | TTTHSWVSG | T | 2 | 648 | MS | HTP | unambiguous | human | HEK 293T cells | 37541260 | |
| 10036820 | TSSNASTISGR | 317 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | |||
| 10037295 | TTTHSWVSG | 648 | MS | HTP | unambiguous | human | HEK 293T cells | 30620550 | Peptide quantification value was applied to each modification site | ||
| 10037387 | TTTHSWVSG | 648 | MS | HTP | unambiguous | human | HepG2 cells | 30620550 | Peptide quantification value was applied to each modification site |